Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Cell Culture Media, Supplements, and Reagents
  4. Cell Culture Media
  5. Cell Target Type Cell Culture Media
  6. Stem Cell Culture Media
  7. SCR544

MilliporeSigma™ Human STEMCCA Constitutive Polycistronic Lentivirus Reprogramming Kit

Catalog No. SCR544
Click to view available options
Quantity:
1 Kit

Description

contains high titer polycistronic lentivirus and Polybrene transfection reagent that have been validated for the generation of human iPS cells from human foreskin fibroblasts.

The Human STEMCCA Constitutive Polycistronic (OKSM) Lentivirus Kit contains high titer polycistronic (OKSM) lentivirus and Polybrene transfection reagent that have been validated for the generation of human induced pluripotent stem cells from human foreskin fibroblasts (HFFs). The STEMCCA vector is comprised of the transcription factors human Oct-4, Klf4, SOX-2, and c-Myc (OKSM), separated by the self-cleaving 2A peptide and IRES sequences (Sommer CA, 2009). The use of a single polycistronic lentiviral vector significantly improves reprogramming efficiencies and reduces the number of viral integrations.
TRUSTED_SUSTAINABILITY

Specifications

Quantity 1 Kit
Content And Storage Human STEMCCA Constitutive (OKSM) Lentivirus: (Mfr. No. SCR544-1) Two (2) vials of EF1α-hSTEMCCA (OKSM) Lentivirus (Mfr. No. CS204502). Each vial contains 15μL of high titer lentivirus. Polybrene Transfection Reagent: (Mfr. No. TR-1003-50UL) One (1) vial containing 50μL of 10mg/mL stock> Store at -80°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.